Amryt Pharma plc (AMYT) Analyst Estimates Quarterly - Discounting Cash Flows
AMYT
Amryt Pharma plc
AMYT (NASDAQ)
Period Ending: 2025
03-30
2024
12-30
2024
09-30
2024
06-30
2024
03-30
2023
12-30
2023
09-30
2023
06-30
2023
03-30
2022
12-30
Number of Analysts 1 1 1 1 1 1 1 1 1 1
Estimated Revenue
Low 190.1 169.7 151.5 135.2 120.7 107.8 96.23 85.91 76.7 68.47
Average 190.1 169.7 151.5 135.2 120.7 107.8 96.23 85.91 76.7 68.47
High 190.1 169.7 151.5 135.2 120.7 107.8 96.23 85.91 76.7 68.47
Estimated EBITDA
Low -86.58 -77.3 -69.01 -61.6 -55 -49.1 -43.83 -39.13 -34.93 -31.19
Average -86.58 -77.3 -69.01 -61.6 -55 -49.1 -43.83 -39.13 -34.93 -31.19
High -86.58 -77.3 -69.01 -61.6 -55 -49.1 -43.83 -39.13 -34.93 -31.19
Estimated EBIT
Low -112.8 -100.7 -89.87 -80.24 -71.63 -63.95 -57.09 -50.97 -45.5 -40.62
Average -112.8 -100.7 -89.87 -80.24 -71.63 -63.95 -57.09 -50.97 -45.5 -40.62
High -112.8 -100.7 -89.87 -80.24 -71.63 -63.95 -57.09 -50.97 -45.5 -40.62
Estimated Net Income
Low 0 0 0 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0 0 0 0
Estimated SGA Expenses
Low 131.1 117.1 104.5 93.29 83.29 74.35 66.38 59.26 52.9 47.23
Average 131.1 117.1 104.5 93.29 83.29 74.35 66.38 59.26 52.9 47.23
High 131.1 117.1 104.5 93.29 83.29 74.35 66.38 59.26 52.9 47.23
Estimated EPS
Low 0 0 0 0 0 0 0 0 0 0
Average 0 0 0 0 0 0 0 0 0 0
High 0 0 0 0 0 0 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program